Prevention of embolism in atrial fibrillation

Abstract

References

Kannel WB , Abbott RD , Savage DD , McNamara PM Epidemiologic features of chronic atrial fibrillation: the Framingham Study . N Engl J Med 1982; 306: 1018-22.

Wolf PA , Abbott RD , Kannel WB Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987; 147: 1561.

Halperin JL , Hart RG Atrial fibrillation and stroke: new ideas, persisting dilemmas. Stroke 1988; 19: 937-41.

Sherman DG , Dyken ML , Fisher M. et al. Cerebral embolism. Chest 1986 ; 89 (suppl): 82.

Dunn M. , Alexander J. , de Silva R. et al. Antithrombotic therapy in atrial fibrillation. Chest 1989; 95 (suppl): 118.

Sherman DG , Dyken ML , Fisher M. et al. Antithrombotic therapy for cerbrovascular disorders. Chest 1989; 95 (suppl): 140.

Sage JI , Van Uitert RL Risk of recurrent stroke in patients with atrial fibrillation and nonvalvular heart disease. Stroke 1983; 14: 537.

Hurley DM , Hunter AN , Hewett MJ et al. Atrial fibrillation and arterial embolism in hyperthyroidism . Aust N Z J Med 1981; 11: 391.

Yuen Rwm , Gutteridge DH , Thompson PL et al. Embolism in thyrotoxic atrial fibrillation. Med J Aust 1979; 1: 630.

10.

Staffurth JS , Gibberd MC, Tang Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 1977; vmr-2: 688.

11.

Bar-Sela S. , Ehrenfeld M. , Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 1981; 141: 1191.

12.

Petersen P. , Hansen JM Stroke in thyrotoxicosis with atrial fibrillation . stroke 1988; 19: 15.

13.

Brand FN , Abbott RD , Kannel WB et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA 1985 ; 254: 3449.

14.

Kopecky SL , Gersh BJ , McGoon MD et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987 ; 317: 669.

15.

Wolf PA , Kannel WB , McGee DL et al. Duration of atrial fibrillation and imminence of stroke: the Framingham Study. Stroke 1983; 14: 664.

16.

Petersen P. , Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986; 17: 622.

17.

Wiener I. , Hafner R. , Nicolai M. et al. Clinical and echocardiographic correlates of systemic embolism in nonrheumatic atrial fibrillation. Am J Cardiol 1987; 59: 177.

18.

Caplan LR , D'Cruz I. , Hier DB et al. Atrial size, atrial fibrillation and stroke. Ann Neurol 1986; 19: 158.

19.

Tegeler CH , Hart RG Atrial size, atrial fibrillation and stroke. Ann Neurol 1987; 21: 315.

20.

Chesebro JH , Fuster V. , Halperin JL Atrial fibrillation - risk marker for stroke . N Engl J Med 1990; 323: 1556.

21.

Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989; 46: 727-43.

22.

Stein B. , Fuster V. , Halperin JL , Chesebro JH Antithrombotic therapy in cardiac disease: an emerging approach based on pathogenesis and risk. Circulation 1989; 80: 1501-13.

23.

Tegeler CH Stroke prevention in atrial fibrillation study: Carotid Stenosis Study Group: carotid stenosis in atrial fibrillation. Neurology 1989; 39 (suppl): 159.

24.

Weinberger J. , Rothlauf EB , Materese E. , Halperin JL Noninvasive evaluation of the extracranial carotid arteries in patients with cerebrovascular events and atrial fibrillation . Arch Intern Med 1988; 148: 1785-88.

25.

Shresta NK , Moreno FL , Narciso FV et al. Two-dimensional echocardiographic diagnosis of left atrial thrombus in rheumatic heart disease: a clinicopathologic study. Circulation 1983 67: 341.

26.

Petersen P. , Boysen G. , Godtfredsen J. , Andersen ED , Andersen B. Placebo controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989; i: 175-79.

27.

Stroke Prevention in Atrial Fibrillation Study Group Investigators. Preliminary report of the Stroke Prevention in Atrial Fibrillation study. N Engl J Med 1990; 322: 863-68.

28.

The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.

29.

Conolly SJ , Laupacis A. , Gent M. , Roberts RS , Cairns JA , Joyner C. Canadian Atrial Fibrillation (CAFA) Study. Circulation 1990; 82 (suppl): 108.

30.

Stein B. , Halperin JL , Fuster V. Should patients with atrial fibrillation be anticoagulated prior to and chronically following cardioversion? In: Cheitlin MD ed. Dilemmas in clinical cardiology. Philadelphia : FA Davis Co, 1990: 231-47.

31.

Bjerkelund CJ , Orning OM An evaluation of DC shock treatment of atrial arrhythmias: immediate results and complications in 437 patients, with long term results in the first 290 of these. Acta Med Scand 1968; 184: 481.

32.

Bjerkelund CJ , Orning OM The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation. Am J Cardiol 1969; 23: 208.

33.

Mancini Gbj , Goldberger AL Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success . Am Heart J 1982; 104: 617.

34.

Ikram H. , Nixon Pgf , Arcan T. Left atrial function after electrical conversion to sinus rhythm. Br Heart J 1968; 30: 80.

35.

Rowlands DJ , Logan Wfwe , Howitt E. et al. Atrial function after cardioversion . Am Heart J 1967; 74: 149.

36.

Manning WJ , Leeman DE , Gotch PJ et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989; 13: 617.

37.

Coplen SE , Antmann EM , Berlin JA , Hewitt P. , Chalmers TC Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized controlled trials. Circulation 1990; 82: 1106-16.

38.

Feld GK Atrial fibrillation: is there a safe and highly effective treatment? Circulation 1990; 82: 2248-50.